.Attributes Medication, Posted online: 30 July 2024 doi:10.1038/ d41591-024-00054-wThe antitoxin-- medication conjugate (ADC) tisotumab vedotin led to boosted progression-free and also overall survival, causing FDA commendation as well as a new treatment option for clients.